Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Sold by Capital Investment Advisory Services LLC

Capital Investment Advisory Services LLC cut its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 6.4% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 437 shares of the medical equipment provider’s stock after selling 30 shares during the quarter. Capital Investment Advisory Services LLC’s holdings in Intuitive Surgical were worth $228,000 as of its most recent SEC filing.

Several other institutional investors have also modified their holdings of ISRG. Berbice Capital Management LLC purchased a new position in Intuitive Surgical during the fourth quarter worth about $26,000. Godsey & Gibb Inc. raised its position in shares of Intuitive Surgical by 140.0% during the 3rd quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider’s stock valued at $29,000 after buying an additional 35 shares during the period. MidAtlantic Capital Management Inc. acquired a new position in Intuitive Surgical in the third quarter valued at approximately $33,000. Decker Retirement Planning Inc. purchased a new position in Intuitive Surgical in the fourth quarter worth approximately $36,000. Finally, Capital Performance Advisors LLP acquired a new stake in Intuitive Surgical during the third quarter worth $38,000. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Analyst Ratings Changes

A number of research firms have recently weighed in on ISRG. Truist Financial increased their price target on Intuitive Surgical from $640.00 to $666.00 and gave the stock a “buy” rating in a report on Friday, January 24th. Morgan Stanley raised shares of Intuitive Surgical from an “equal weight” rating to an “overweight” rating and boosted their price target for the company from $522.00 to $650.00 in a research note on Monday, December 2nd. Erste Group Bank upgraded shares of Intuitive Surgical from a “hold” rating to a “buy” rating in a report on Tuesday, November 19th. Jefferies Financial Group upped their price target on Intuitive Surgical from $475.00 to $575.00 in a research note on Monday, January 27th. Finally, Bernstein Bank lifted their price objective on Intuitive Surgical from $655.00 to $700.00 and gave the company an “overweight” rating in a research note on Monday, January 27th. One equities research analyst has rated the stock with a sell rating, five have given a hold rating and sixteen have assigned a buy rating to the company. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average target price of $613.10.

Insider Buying and Selling at Intuitive Surgical

In related news, EVP Robert Desantis sold 376 shares of the company’s stock in a transaction dated Friday, November 29th. The stock was sold at an average price of $539.00, for a total value of $202,664.00. Following the completion of the sale, the executive vice president now directly owns 5,506 shares of the company’s stock, valued at $2,967,734. This represents a 6.39 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Jamie Samath sold 22,903 shares of Intuitive Surgical stock in a transaction that occurred on Friday, November 8th. The stock was sold at an average price of $525.00, for a total value of $12,024,075.00. Following the transaction, the insider now directly owns 8,757 shares in the company, valued at approximately $4,597,425. This trade represents a 72.34 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 28,843 shares of company stock worth $15,357,560 over the last three months. Insiders own 0.90% of the company’s stock.

Intuitive Surgical Stock Performance

NASDAQ:ISRG opened at $571.88 on Friday. Intuitive Surgical, Inc. has a 1 year low of $364.17 and a 1 year high of $616.00. The stock has a market cap of $203.69 billion, a P/E ratio of 89.22, a P/E/G ratio of 5.52 and a beta of 1.39. The stock has a 50-day simple moving average of $549.92 and a 200-day simple moving average of $508.00.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.